InsidersTradesSigma
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (0 ops.)
Browse the detailed record of transactions filed by FLAVIN JOHN L, Director. Director active across 1 companies, notably Pyxis Oncology, Inc.. Cumulatively, 3 reports have been recorded. The latest transaction was disclosed on 31 March 2022 — Attribution. Regulator: SEC (Form 4). The full history is accessible without signup.
Declarations3 total
066,831 shares0
Common Stock
SEC:0001140361-22-012921:0·
2,388 shares
Common Stock
SEC:0001140361-21-034643·
2,388 shares
Common Stock
SEC:0001140361-21-034643:0·
3 of 3 declarations
About FLAVIN JOHN L
John L. Flavin is a Board Member at Pyxis Oncology, Inc. He plays an active role in the governance of the company, bringing his expertise in biotechnology and strategy. Flavin contributes to important decision-making and the strategic direction of Pyxis Oncology.
